# GlycoFi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glycofi

- Industry: Biotechnology
- Headquarters: Lebanon, US
- Total disclosed funding: $29M
- Latest round: Series C (Oct 10, 2005)
- Investors on record: 9

## About

Founded in 2000, GlycoFi, Inc. engages in the creation of bio-therapeutics based on glycan optimization technology.

## Funding rounds

- Series C, Oct 10, 2005, $11M — Boston Millennia Partners, Polaris Partners, Fletcher Spaght Ventures, SV Health Investors, Peninsula Ventures, Village Ventures, Borealis Ventures, International Biotechnology Trust, Eli Lilly & Company
- Series C, Dec 10, 2003, $10M — Boston Millennia Partners, Polaris Partners, Fletcher Spaght Ventures, SV Health Investors, Village Ventures, Borealis Ventures
- Series B, Apr 29, 2002, $7M — Boston Millennia Partners, Polaris Partners, SV Health Investors, Borealis Ventures
- Series A, Jun 1, 2001, $0.6M — Polaris Partners

## Investors

- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C
- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series B, Series C
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B, Series C
- Borealis Ventures (https://capitalatlas.ai/funds/borealis-ventures) — Series B, Series C
- Fletcher Spaght Ventures (https://capitalatlas.ai/funds/fletcher-spaght-ventures) — Series C
- Village Ventures (https://capitalatlas.ai/funds/village-ventures) — Series C
- Peninsula Ventures (https://capitalatlas.ai/funds/peninsula-ventures) — Series C
- International Biotechnology Trust — Series C
- Eli Lilly & Company — Series C